Bundibugyo Ebola virus outbreak: launch of the EBO-PEP trial to protect high-risk contacts
Paris – Kinshasa, 14 July 2026. The National Institute for Biomedical Research (INRB) in Kinshasa, the ANRS Emerging infectious diseases
Paris – Kinshasa, 14 July 2026. The National Institute for Biomedical Research (INRB) in Kinshasa, the ANRS Emerging infectious diseases
In Nigeria, Lassa fever continues to affect communities, with 793 confirmed cases and 204 deaths reported by the NCDC in
In the N’Gouri district, the OptiMAx project combines vaccination with nutritional supplementation to encourage families to return to health centers.
In the Democratic Republic of the Congo and Niger, the OptiMA clinical trials successfully combined scientific rigor with operational constraints
Every year, millions of children in Africa are trapped in a vicious cycle of malnutrition and infectious diseases. But what
A decisive new step has been taken in the fight against the Ebola virus. According to a PREVAC study conducted
The waste of two essential items in the healthcare and nutritional response in sub-Saharan Africa poses significant environmental pollution. How
Collaboration between researchers and humanitarians is key to transforming medicine in Africa. Our new web series explores how these professionals
Nearly two years after publishing its environmental roadmap, ALIMA presents its first progress report with achievements and lessons learned since
Nigeria enters Lassa fever peak season with new outbreaks underway Abuja, Nigeria, 27 February 2024 – A first-of-its-kind global alliance
We offer country-specific donation forms to give you access to local payment options and tax benefits.